Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 14 NOVEMBER 2017

Ferrari's TESTAROSSA Trademark Extinguished In Germany

Fasken
Explore more from Fasken

A German court has ruled that Ferrari, famous maker of Italian sports cars, must give up its TESTAROSSA trademark in that country.

GermanyIntellectual Property
Simon Hitchens
Simon Hitchens
Mark Vanderveken
Mark Vanderveken
Author LinkedIn connections

A German court has ruled that Ferrari, famous maker of Italian sports cars, must give up its TESTAROSSA trademark in that country. The ruling will come as a blow to one of the most famous trademarks in automotive history and serves as a warning that brand owners should not assume their legacy marks are safe, no matter how well known they are.

Ferrari used the TESTAROSSA trademark from 1984 until 1991, when TESTAROSSA production ended. During that time, the TESTAROSSA became an iconic sports car known to motor enthusiasts everywhere. However, sports cars bearing the TESTAROSSA trademark have not been sold by Ferrari (as opposed to within the second hand market) since it went out of production.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Kraftwerk Sampling Ruling: Pastiche Finds Its Rhythm

Germany's highest civil court has ruled that an unlicensed sample from Kraftwerk's 1977 track "Metall auf Metall" used in a hip hop song qualifies as lawful pastiche under EU copyright law. This landmark decision, concluding a nearly 30-year legal dispute, establishes new parameters for when sampling can constitute creative engagement rather than mere copying, though it stops short of providing blanket protection for all unauthorized samples.
European UnionIntellectual Property
Lewis Silkin
Lewis Silkin
Article

LD Düsseldorf, August 17, 2026, Order, UPC_CFI_1034/2025, UPC_CFI_931/2026

The Local Division Düsseldorf of the Unified Patent Court issued an order addressing applications for protection of confidential information in patent infringement proceedings between Yangtze Memory Technologies and Micron Technology entities. The case involves European Patent EP 3 909 047 with jurisdictional implications across Germany and France under the UPC Agreement.
GermanyIntellectual Property
Bardehle Pagenberg
Bardehle Pagenberg
Article

More Than Skin Deep: Ontario Considers A Makeover Of Cosmetic Injection Rules

A regulatory shift now under consideration in Ontario could reshape how the province’s medical aesthetic clinics operate. The proposal, which would change how nurses are authorized to administer medical aesthetic services, invites a broader look at how Ontario currently regulates cosmetic injections and how the proposed changes would align the province more closely with the regulatory frameworks already in place elsewhere in Canada. While these procedures are often marketed as routine “spa” services, they remain medical acts that involve prescription products and carry clinical risks.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
Article

Canada’s Counter-Tariffs On US Goods: A Primer On What Canadian Businesses Need To Know

Effective September 8, 2026, Canada implemented retaliatory tariffs on certain U.S. goods in response to the initial 50% tariffs imposed by the US under Section 338 of the Tariff Act of 1930. To operationalize these measures, the Canada Border Services Agency (CBSA) issued Customs Notice 26-23, establishing binding administrative rules on how the surtax will be applied, calculated, and collected.
CanadaInternational Law
Fasken
Fasken
Article

2026 Federal Budget: Highlights Affecting Financial Services

The 2026 Federal Budget (“Budget 2026”) proposes to grow the Canadian financial services sector, while introducing multiple checks on possible risks raised by new bank entrants and innovative technology. It also builds out existing policy measures to support digital innovation and combat fraud. There are various other measures that may be of interest to financial service providers in banking, insurance and payments.
CanadaFinance and Banking
Fasken
Fasken
Article

Open Banking Milestone: Draft Supervisory Guidelines For Consumer-Driven Banking Released

The Bank of Canada (the “Bank”) has published two proposed guidelines relating to the accreditation process for prospective participants under the Consumer-Driven Banking Framework: the Participating entity accreditation application requirements under the Consumer-Driven Banking Act (the “Participating Entity Guideline”) and the Third-party service provider accreditation application requirements under the Consumer-Driven Banking Act (the “TPSP Guideline”).
CanadaFinance and Banking
Fasken
Fasken
Article

Life Sciences-Health Canada Takes Action Against Unauthorized Peptide Sales

On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.
CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken